Scrambler Therapy for Pain Management: A Review of Clinical Evidence

Scrambler Therapy is a non-invasive electroanalgesia method that has demonstrated promise in managing various pain conditions. Scrambler Therapy is FDA-approved and seeks to relieve pain through neuromodulation, replacing pain signals with “non-pain” information.

Mechanisms of Action

Scrambler Therapy’s mechanism of action differs from other electroanalgesic techniques like TENS and includes:

• Stimulation of C fibers using weak electrical impulses.
• Synthesis of 16 distinct types of nerve action potentials and assembling them into sequences.
• A proprietary software algorithm continuously changes 256 distinct sequences to “scramble” noxious stimuli into non-painful sensations.
• Mitigation of central sensitization.
• Resetting central sensitization by increasing top-down inhibition and reducing excitatory activity.
• Each electrode pair acts as an artificial neuron, capturing the surface receptors of the c-fibers and replacing the pain signal with a “non-pain signal”.
• Redirection of cerebral blood flow from pain centers to frontal inhibitory centers.
• Restoration of the serum balance of pain-activating and inhibitory mRNAs and their proteins.

Clinical Applications

Scrambler Therapy has applications in treating a range of pain conditions, including:

• Chemotherapy-Induced Peripheral Neuropathy (CIPN):
  • Scrambler Therapy was more effective than TENS in alleviating CIPN symptoms.
  • In one study, twice as many Scrambler Therapy-treated patients experienced a ≥50% reduction in pain, tingling, and numbness, compared to those treated with TENS.
  • Loprinzi, et al. showed 40% of Scrambler Therapy patients versus 20% of TENS patients reported a 50% or more reduction in pain from baseline.
• Poststroke Pain:
  • Scrambler Therapy may offer a new intervention for poststroke pain, providing more effective therapy without medication toxicity or significant long-lasting side effects.
  • Stowell-Campos, et al. showed 9 out of 10 patients treated with Scrambler Therapy experienced some improvement in their pain scores over 5 treatment sessions.
• Diabetic Peripheral Neuropathy:
  • Scrambler Therapy is effective in treating diabetic peripheral neuropathy, even when oral analgesics and nerve block therapy are ineffective.
  • Park HS, et al. found that pain management can be achieved for patients with general sole pain, including toe pain, by attaching scrambler patches around the ankle.
• Chronic Neuropathic Pain:
  • Scrambler Therapy was more effective than guideline-based drug management in relieving chronic neuropathic pain.
  • Marineo, et al. reported patients receiving Scrambler Therapy experienced a 91% reduction in pain which persisted for at least 3 months.
  • A meta-analysis indicated that Scrambler Therapy decreased pain scores.
• Pediatric Neuropathic Pain:
  • Tomasello, et al. indicates Scrambler Therapy may be a promising, effective, and safe treatment option for pediatric patients with chemotherapy-related neuropathic pain.
  • The study showed relief or dramatic reduction in NP and improvement in the QOL in a small cohort of patients previously unresponsive to drug therapy.
• HIV-Related Peripheral Neuropathy:
  • Scrambler Therapy was the first published use of a non-invasive pain modality for HIV peripheral neuropathy.
  • A case report indicated that Scrambler Therapy reduced pain, enabling the patient to discontinue morphine and oxycodone.
• Small Fiber Neuropathy
  • Tovar Sanchez, et al. reported compared to other neuropathies that have responded to Scrambler Therapy, SFN appears to take more sessions and lose effectiveness sooner.

Scrambler Therapy Protocol

Key aspects of the Scrambler Therapy protocol include:

• Electrode Placement: Up to five pairs of electrodes are placed proximally and distally to the pain site along the affected dermatome.
• Treatment Sessions: Scrambler Therapy is administered in scheduled sessions at a healthcare facility. Each Scrambler Therapy patient was given a 45-minute daily treatment for 10 consecutive days, Monday through Friday.
• Stimulus Intensity: The stimulus is increased to the maximum intensity that the patient can tolerate without causing additional pain or discomfort.

Scrambler Therapy vs. TENS

Scrambler Therapy and TENS both use electrical stimulation but differ in several aspects:

• Mechanism: TENS primarily inhibits nociception transmission via A-beta fiber stimulation, whereas Scrambler Therapy aims to replace pain signals with non-pain signals.
• Waveforms: Scrambler Therapy employs a complex algorithm with varying waveforms, while TENS typically uses an on-off biphasic current without variation.
• Efficacy Duration: Scrambler Therapy has shown analgesic effects lasting weeks to months, whereas TENS’s effects are often limited to the treatment period.
• Clinical Use: TENS therapy is effective in postoperative and musculoskeletal pain.

Safety Profile

Scrambler Therapy is generally considered safe, with a low incidence of adverse effects:

• Adverse Events: The adverse event rate is only 0.03%, consisting at most of a bruise or slight redness under the electrodes.
• Contraindications: Scrambler Therapy is contraindicated in patients with implanted pacemakers, defibrillators, spinal cord or peripheral-nerve stimulators, and uncontrolled epilepsy.

Scrambler therapy presents a promising non-invasive treatment for various pain conditions, especially neuropathic pain.. Its unique mechanism of action and favorable safety profile make it a valuable option for patients seeking pain relief. Future research should prioritize larger, well-controlled trials to confirm its efficacy and explore its potential across different clinical settings. Continued research will optimize long-term protocols and enhance its effectiveness for those in need.

References

Loprinzi, C., Le-Rademacher, J. G., Majithia, N., McMurray, R. P., O’Neill, C. R., & Bendel, M. A. (2020). Scrambler therapy for chemotherapy neuropathy: a randomized phase II pilot trial. Supportive Care in Cancer, 28(3), 1183-1197.

Marineo, G., Iorno, V., Gandini, C., Moschini, V., & Smith, T. J. (2012). Scrambler therapy may relieve chronic neuropathic pain more effectively than guideline-based drug management: Results of a pilot, randomized, controlled trial. Journal of Pain and Symptom Management, 43(1), 87-95.

Park, H. S., Kim, W. J., Kim, H. G., et al. (2017). Scrambler therapy for the treatment of neuropathic pain related to leukemia in a pediatric patient: A case report. Medicine, 96(50), e8629.

Park HS, Sin WK, Kim HY, et al. Scrambler therapy for patients with cancer pain—case series. Korean J Pain. 2013;26(1):65-71.

Stowell-Campos, R., Lawrence, E., Breese Marsh, E., & Merbach, D. (2024). Scrambler therapy for treatment of poststroke pain. Annals of Clinical and Translational Neurology, 11(11), 2904-2911.

Tomasello, C., Pinto, R. M., Mennini, C., Conicella, E., Stoppa, F., & Raucci, U. (2018). Scrambler therapy efficacy and safety for neuropathic pain correlated with chemotherapy-induced peripheral neuropathy in adolescents: A preliminary study. Pediatric Blood & Cancer, 65(2), e27064.

Tovar Sanchez, K. T., & Smith, T. J. (2024). Fellows research article: use of scrambler therapy to treat small fiber neuropathy. Pain Medicine, 25(2), 157-160.